PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: AccuVein, LLC

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

AccuVein Secures $22.5 Million Series B Financing through MVM Life Science Partners and Bessemer Venture Partners - Funding to support expanded growth of Vein illumination leader - AccuVein.com
AccuVein Secures $22.5 Million Series B Financing through MVM Life Science Partners and Bessemer Venture Partners

 

NewswireToday - /newswire/ - Long Island, NY, United States, 2011/07/28 - Funding to support expanded growth of Vein illumination leader - AccuVein.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Bednarski and Gabrieli to Join Board of Directors

AccuVein, Inc., a global leader in medical imaging technology and the creator of the AV300, the world’s first hand-held, non-contact vein illumination device, announced today that it has secured $22.5 million in a Series B financing. The company is expected to use the growth capital to continue its expansion into untapped markets and to enhance its focus on global customers.

MVM Life Science Partners and Bessemer Venture Partners led the financing round. Current investors also participated. In connection with the financing, Eric Bednarski of MVM Life Science Partners and Christopher Gabrieli of Bessemer Venture Partners have joined the AccuVein board. Aquilo Partners, L.P., a life science investment bank, acted as the exclusive placement agent for the financing.

“We are impressed by AccuVein’s proprietary technology and commercial execution and are excited to work with the company to improve patient care by making vein illumination broadly available to patients and clinicians,” said Dr. Bednarski, partner at MVM.

Christopher Gabrieli, partner at Bessemer, added,“AccuVein has developed a unique, innovative product with potential in multiple markets. We look forward to working with Ron and the team as they continue to expand their global footprint.”

“We are very fortunate to be partnering with proven investors that fully support our efforts to continue to make vein illumination part of the industry standard of care,” said Ron Goldman, AccuVein CEO,“They clearly recognize the vast potential and future medical imaging applications of our technology and intellectual property.”

AccuVein’s industry-leading and award-winning AccuVein AV300 vein illumination solution is in use at more than 750 U.S. hospitals and available for sale in 63 countries. The AV300 has been shown to improve peripheral vascular access for IV infusion by projecting a safe pattern of light on patient’s skin that reveals the position of underlying veins.

Venipuncture is the most common invasive medical procedure worldwide with an estimated 2.7 million procedures conducted every day in the United States alone. Studies show that up to one third of these attempts to access a vein fail the first time, creating unnecessary patient discomfort as well as additional costs.

The AccuVein AV300 has received high praise from doctors, nurses, hospital administrators, patients and families for saving time and money and for improving patient care. The technology has also received numerous awards and widespread recognition from within the health care sector, including the top “gold” prize in the prestigious MDEA design competition as well as the 2011 Frost & Sullivan New Product Innovation Award.

About AccuVein, Inc.
AccuVein, Inc. (accuvein.com) is a global leader in medical imaging solutions. Its breakthrough product, the AV300, allows health care professionals to see a map of peripheral veins on the skin’s surface with the goal of improving vascular access procedures including blood draw, IV infusion and blood donation.

The AV300 is the world’s only handheld, non-contact vein illumination solution. It is built on AccuVein’s proprietary technology as embodied in its growing patent portfolio that covers a broad range of imaging and medical diagnostic technologies.

It is in use at more than 750 U.S. hospitals and available for sale in 63 countries worldwide.

About MVM Life Science Partners
MVM Life Science Partners LLP (mvmlifescience.com) invests in select opportunities in healthcare. MVM was founded in 1997 and has a complimentary team with broad experience in London and Boston.

About Bessemer Venture Partners
Bessemer Venture Partners (bvp.com) is a global venture capital firm with offices in Silicon Valley, Cambridge, Mass., New York, Mumbai and Herzliya, Israel. One of the oldest venture capital practices in the United States, BVP has partnered as an active, hands-on investor in Ciena, LinkedIn, Celtel, Blue Nile, Skype, Staples, VeriSign and Yelp. More than 100 BVP-funded companies have gone public on exchanges in Canada, India, the U.K. and the United States.
BVP’s healthcare team has a diversity of industry experience, backing developers of innovative therapeutics, providers of healthcare services and suppliers of healthcare information technology. The team has worked successfully with entrepreneurs at Vistacare, Allscripts, IPC The Hospitalist Company, Travcorps and NetSmart.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: AccuVein, LLC

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


AccuVein Secures $22.5 Million Series B Financing through MVM Life Science Partners and Bessemer Venture Partners

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

AccuVein, LLC |
Publisher Contact: Press Office - AccuVein.com 
816-997-9400 info[.]accuvein.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any AccuVein, LLC securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From AccuVein, LLC / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Sparta Systems Broadens Partnership with TrackWise Implementation Specialist Equality Systems
Thales Launches the Pixium Portable 3543 DR Wifi Enabled Flat Panel Detector
GE Healthcare Showcases Industry-first Technologies and Digital Solutions, Focused on Improving Outcomes, At RSNA 2016
Agfa and LCsys Team Up to Launch ABSOLUT-ID, Their Turnkey Integrated Solution for the Production of High Security ID Cards
ZOLL Technology for Improving CPR Quality to be Showcased at American Heart Association Annual Conference
AccuVein to Exhibit Leading Vein Visualization Technology at American Society for Dermatologic Surgery Annual Meeting
US Biomedical Textiles Transform Implant Device Technology by Aligning to Changes in Patient Preference Finds Frost & Sullivan
Frost & Sullivan Commends Influence Health for Constantly Evolving its Patient Engagement Products to Accelerate Market Transformation
Frost & Sullivan Awards Carestream Top Honors for OnSight 3D Extremity System
Sparta Systems Launches the Next-Generation Cloud Solution Stratas QMS
Koning Wins Accolades from Frost & Sullivan for the Impressive Innovation Behind its Groundbreaking KBCT Breast Imaging Device
Frost & Sullivan Awards ResMed for Developing S+ Advanced Sleep Tracking System
Sparta Systems Becomes First Quality Management Solutions Provider to Achieve EU-U.S. Privacy Shield Compliance
ZOLL Expands the Rescuer Experience at EMS World Expo
Agfa and GPMI Sign Distribution Agreement for Agfa’s Synthetic Paper Synaps

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)